Neuraptive secures exclusive licence from Washington University for nerve device

Neuraptive Therapeutics has secured an exclusive licence from Washington University in St. Louis for a bioresorbable wireless electronic stimulation device designed for peripheral nerve repair. The deal grants Neuraptive rights to commercialize the technology, which represents a strategic licensing partnership in the neurology device space.